1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Medullary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Medullary Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Medullary Thyroid Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Medullary Thyroid Cancer 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Medullary Thyroid Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
Exelixis, Inc. 32
Clinical Trial Overview of Exelixis, Inc. 32
Eisai Co., Ltd. 33
Clinical Trial Overview of Eisai Co., Ltd. 33
Sino Biopharmaceutical Limited 34
Clinical Trial Overview of Sino Biopharmaceutical Limited 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
Immunomedics, Inc. 36
Clinical Trial Overview of Immunomedics, Inc. 36
Globeimmune, Inc. 37
Clinical Trial Overview of Globeimmune, Inc. 37
EANM Research Ltd. 38
Clinical Trial Overview of EANM Research Ltd. 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Amgen Inc. 40
Clinical Trial Overview of Amgen Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
University of Kentucky 43
Clinical Trial Overview of University of Kentucky 43
University of Wisconsin Madison 44
Clinical Trial Overview of University of Wisconsin Madison 44
Garden State Cancer Center 45
Clinical Trial Overview of Garden State Cancer Center 45
University of Texas M. D. Anderson Cancer Center 46
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 46
University of Southern California 47
Clinical Trial Overview of University of Southern California 47
Sidney Kimmel Comprehensive Cancer Center 48
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Leiden University Medical Center 51
Clinical Trial Overview of Leiden University Medical Center 51
Five Key Clinical Profiles 52
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109

List of Tables
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Medullary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Medullary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Medullary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Medullary Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Medullary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Medullary Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Medullary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 31
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 32
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 33
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sino Biopharmaceutical Limited, 2015* 34
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 35
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2015* 36
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Globeimmune, Inc., 2015* 37
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EANM Research Ltd., 2015* 38
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 40
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 41
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 43
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015* 44
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Garden State Cancer Center, 2015* 45
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 46
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015* 47
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2015* 48
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 49
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 50
Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 51

List of Figures
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Medullary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Medullary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Medullary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Medullary Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Medullary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Medullary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...


Download Unlimited Documents from Trusted Public Sources

Prostate Cancer Statistics in the US

  • February 2017
    14 pages
  • Prostate Cancer  

  • United States  

View report >

Colorectal Cancer Statistics in Spain

  • February 2017
    11 pages
  • Colorectal Canc...  

  • Spain  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Related Market Segments :

Cancer
Clinical Trial
Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.